Isolate Data
Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
DT0917_05_P1 | 917 | Uganda | 2005 | HIV1 | D | Plasma | None |
Treatment History
Order | Regimen | Weeks |
1 | AZT+3TC+NVP | 48 |
Protease Sequence
PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
I13V, M36I, R41K, L63Q, I64V, E65D |
>917| codons 1-99 PQITLWQRPLVTVKIGGQLKEALLDTGADDTVLEEINLPGKWKPKMIGGIGGFIKVRQYD QIQVDICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF |
RT Sequence
NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
Y188YC | V35T, E36D, T39M, E40D, K49R, V60I, D121Y, K122E, D123E, I135T, S162A, E169ED, D177E, Q207E, R211K |
>917| codons 1-242 PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALTDICMDMEKEGKISRIGPENPYNTPI FAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPL YEEFRKYTAFTIPSTNNETPGIRYQYNVLPQGWKGSPAIFQASMTKILDPFRKQNPEIVI YQYMDDLCVGSDLEIGQHRTKIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWT VQ |
References
Author | Title | Citation |
Ndembi, N | Viral rebound and emergence of drug resistance in the absence of viral load testing: A randomized comparison between zidovudine-lamivudine plus nevirapine and zidovudine-lamivudine plus abacavir. | J Infect Dis, 2010 |